In 1994, Lapidot et al. (1994) first isolated CSCs with immunophenotype CD34+/CD38 − from acute myeloid leukemia (AML) cells, and they confirmed the self-renewal ability of CSCs in mice with severe combined immunodeficiency. This evidence concerns the gene CD38 and acute myeloid leukemia.